IV administration also introduces risks that oral supplementation does not: Contamination or excessive endotoxin exposure Sterility and compounding failures Infusion reactions Venous irritation or infection Dosing errors Additional cost and clinical complexity The FDA has reported adverse events among patients who received injectable compounded glutathione made with an unsuitable dietary ingredient
RELATED: Retatrutide, Eli Lilly's next obesity drug, fueled dramatic weight loss in clinical trial To qualify, besides having Medicare drug coverage, you must have a body mass index of 35 or higher, or a BMI of 27 or higher alongside another health condition, such as a past heart attack or stroke, prediabetes or another from a list on the CMS website
Results were considered significant where probability ( p) 0.05
Moreover, patients should take no more than eight injections within a month
They note that regular follow-ups can help identify any potential side effects or adverse reactions, such as gastrointestinal issues, which are commonly associated with GLP-1 receptor agonists
That's like to be determined
